8-K: Philip Morris International Reaffirms 2025 Full-Year EPS Forecast at CAGNY Conference

Philip Morris International reaffirms its 2025 full-year reported diluted EPS forecast of $6.55 to $6.68 during the Consumer Analyst Group of New York (CAGNY) Conference.

Summary

• Philip Morris International (PMI) presented at the 2025 Consumer Analyst Group of New York (CAGNY) Conference.
• The company reaffirmed its 2025 full-year reported diluted EPS forecast of $6.55 to $6.68.
• Excluding adjustments of $0.49 per share, the adjusted diluted EPS forecast is $7.04 to $7.17, representing a projected increase of 7.2% to 9.1% versus 2024.
• Excluding an adverse currency impact of $0.22 per share, the adjusted diluted EPS growth is projected at 10.5% to 12.5%.
• PMI's smoke-free products were available in 95 markets as of December 31, 2024.
• Approximately 38.6 million adults worldwide use PMI's smoke-free products.
• The smoke-free business accounted for approximately 39% of PMI's total full-year 2024 net revenues.

Sentiment

Score: 7

Explanation: The document conveys a moderately positive sentiment due to the reaffirmation of the EPS forecast and the continued growth in the smoke-free product category. However, the presence of risks and uncertainties tempers the overall optimism.

Positives

• PMI is actively delivering a smoke-free future and evolving its portfolio.
• The company has invested over $14 billion in smoke-free products since 2008.
• PMI acquired Swedish Match in 2022, creating a global smoke-free champion.
• The FDA has authorized the marketing of certain IQOS devices and consumables, as well as Swedish Match's General snus and ZYN nicotine pouches.
• PMI aims to expand into wellness and healthcare areas.

Negatives

• The forecast is subject to risks and uncertainties, including excise tax increases, regulatory restrictions, and health concerns related to tobacco and nicotine use.
• Unfavorable currency exchange rates and currency devaluations could adversely affect results.
• The company faces intense competition and the risk of lost revenues due to counterfeiting and contraband.

Risks

• Excise tax increases and discriminatory tax structures could negatively impact PMI's business.
• Increasing marketing and regulatory restrictions could reduce competitiveness.
• Health concerns related to tobacco and nicotine use may affect demand.
• Litigation related to tobacco and nicotine use poses a risk.
• Global economic, regulatory, and political developments, including the impact of Russia's invasion of Ukraine, could have adverse effects.
• Adverse changes in corporate tax laws could impact profitability.
• The company faces risks related to the cost, availability, and quality of tobacco and other raw materials.
• The integrity of information systems and data privacy policies is a concern.

Future Outlook

PMI reaffirms its 2025 full-year reported diluted EPS forecast and expects growth in adjusted diluted EPS, particularly when excluding currency impacts. The company aims to continue delivering a smoke-free future and expanding into wellness and healthcare areas.

Management Comments

• PMI's Chief Executive Officer, Jacek Olczak, and Chief Financial Officer, Emmanuel Babeau, addressed investors at the CAGNY Conference.
• The presentation covered PMI's progress in delivering a smoke-free future, the financial model underlying superior returns to shareholders, and the success and future opportunities for smoke-free brands.

Industry Context

PMI's focus on smoke-free products aligns with the broader industry trend of reducing harm and offering alternatives to traditional cigarettes. The company's investments in this area and its acquisition of Swedish Match position it as a leader in the smoke-free market.

Comparison to Industry Standards

• PMI's commitment to smoke-free products mirrors similar efforts by competitors like British American Tobacco (BAT) and Altria Group.
• BAT has been focusing on its 'New Categories' business, which includes vapor, tobacco heating products, and oral nicotine, aiming for significant revenue contribution from these products.
• Altria has invested in alternative nicotine products, including oral nicotine pouches and heated tobacco, to diversify beyond traditional cigarettes.
• PMI's 39% revenue contribution from smoke-free products is a significant achievement, placing it among the leaders in the transition towards reduced-risk products.

Stakeholder Impact

• Shareholders can expect continued focus on delivering superior returns.
• Adult smokers will have access to innovative smoke-free products.
• Employees will be involved in the company's transformation towards a smoke-free future.
• The company's expansion into wellness and healthcare areas may benefit consumers.

Next Steps

• PMI will continue to execute its strategy of delivering a smoke-free future.
• The company will focus on growing its smoke-free brands and expanding into wellness and healthcare areas.
• PMI will monitor and manage the risks and uncertainties outlined in the forward-looking statements.

Key Dates

Keywords

Philip Morris International, CAGNY Conference, EPS Forecast, Smoke-Free Products, IQOS, ZYN, Swedish Match, Financial Performance, Tobacco Industry, Harm Reduction